Intimation for approval of investment in units of Vivriti Vihaan Trust, a scheme of an Alternative Investment Fund registeed under SEBI and in units of Neo Income plus Fund III, a scheme of Neo Credit Alternatives Investment Trust.

Date: September 25, 2026 The Bombay Stock Exchange (BSE Limited) Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400001 Scrip Name: AMWILL HEALTH CARE LIMITED. Company Scrip Code.: 544353 Re: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") read with SEBI Master Circular no. (Ref: HO/49/14/14(7)2025-CFD-POD2/I/3762/2026) January 30, 2026 (“SEBI Master Circular”). Subject: Investment in and subscription to Units of Vivriti Vihaan Trust, a scheme of an Alternative Investment Fund registered with SEBI, and Units of Neo Income Plus Fund III, a scheme of Neo Credit Alternatives Investment Trust. Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we hereby inform you that the Investment Committee, at its meeting held today, September 25, 2026, pursuant to the approval accorded by the Investment Committee at its meeting held on August 8, 2026, has approved the following investments to be made from the Company’s internal accruals. 1) Approval to invest up to INR 1,50,00,000/- (Indian Rupees One Crore Fifty Lakh Only) to subscribe to the Units of the scheme of Vivriti Vihaan Trust, a scheme of an Alternative Investment Fund registered with SEBI to support the Company’s long-term growth strategy. 2) Approval to invest up to INR 1,50,00,000/- (Indian Rupees One Crore Fifty Lakh Only) to subscribe in the Units of Neo Income Plus Fund III, a scheme of Neo Credit Alternatives Investment Trust, registered with Securities and Exchange Board of India (“the AIF’’). The initiative is expected to contribute positively to the Company’s financial growth and support its operational objectives. The said investment is proposed to be made in the ensuing month(s). The investment does not involve any related party transaction. This disclosure is being made in compliance with Regulation 30 of the SEBI Listing Regulations and is submitted for your information and record, will be available on the website of the Company www.amwillhealthcare.com. Thanking You. FOR AMWILL HEALTH CARE LIMITED Anshu Anshuman Company Secretary and Compliance Officer ACS65515 Place: Bangalore